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Transcranial direct current stimulation (tDCS) has been suggested as a therapeutic tool for
pain syndromes. Although initial results in human subjects are encouraging, it stillAvailable online 9 October 2012
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remains unclear whether the effects of tDCS can reverse maladaptive plasticity associated
with chronic pain. To investigate this question, we tested whether tDCS can reverse the
specific behavioral effects of chronic stress in the pain system, and also those indexed by
corticosterone and interleukin-1b levels in serum and TNFa levels in the hippocampus, in a
well-controlled rat model of chronic restraint stress (CRS). Forty-one adult male Wistar rats
were divided into two groups control and stress. The stress group was exposed to CRS for
11 weeks for the establishment of hyperalgesia and mechanical allodynia as shown by the
hot plate and von Frey tests, respectively. Rats were then divided into four groups control,
stress, stressþsham tDCS and stressþtDCS. Anodal or sham tDCS was applied for 20 min/
day over 8 days and the tests were repeated. Then, the animals were killed, blood collected
and hippocampus removed for ELISA testing. This model of CRS proved effective to induce
chronic pain, as the animals exhibited hyperalgesia and mechanical allodynia. The hot
plate test showed an analgesic effect, and the von Frey test, an anti-allodynic effect after
the last tDCS session, and there was a significant decrease in hippocampal TNFa levels. the Elsevier OA license.
09
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b r a i n r e s e a r c h 1 4 8 9 ( 2 0 1 2 ) 1 7 – 2 618These results support the notion that tDCS reverses the detrimental effects of chronic
stress on the pain system and decreases TNFa levels in the hippocampus.
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Several pain syndromes, such as fibromyalgia, chronic back
pain, and neuropathic pain, are associated with significant
effects on neuroplasticity in pain-related neural circuits,
which, in turn, lead to significant effects on the sensory
and affective-emotional domains, such as hyperalgesia, allo-
dynia, anxiety and depression (Staud, 2006; Staud and
Rodriguez, 2006). In most cases, these conditions are asso-
ciated with psychiatric disorders, absenteeism, and high
costs of chronic treatment or poor outcomes despite treat-
ment (Jensen et al., 2007; Van Hanswijck de Jonge et al., 2008).
Pain syndromes are associated with chronic stress, as chronic
exposure to pain produces suffering, which activates the
hypothalamic-pituitary-adrenal (HPA) axis, thus stimulating
the production of corticosterone, the hormone released in
stress conditions (for a review, see Martenson et al., 2009). It
is known that serum corticosterone levels in rats subjected to
chronic stress do not show a significant increase in compar-
ison to control animals; however, this increase is statistically
significant when rats are subjected to acute stress (Park et al.,
2012; Torres et al., 2001a).
Unlike acute stress, which has been associated with a
reduction in pain sensitivity, probably mediated by brain
stem pain modulation (for a review, see Martenson et al.,
2009), chronic stress has been associated with decreased pain
thresholds. Indeed, chronic stress is associated with hyper-
algesia (enhanced response to noxious stimuli) (Gamaro
et al., 1998; Torres et al., 2001a; Bardin et al., 2009) and
allodynia (pain induced by non-noxious stimuli) (Bardin
et al., 2009). In the previous study, we demonstrated that
chronic stress-induced hyperalgesia remained for 28 days
after discontinuation of treatment (Torres et al., 2003). Inter-
estingly, the analgesic response to acute restraint stress (i.e.,
inhibition of pain) was re-established only after 14 days of
discontinuation of chronic stress (Torres et al., 2003).
Although the underlying mechanisms of long-lasting hyper-
algesia after chronic stress are still elusive, some studies have
advanced understanding of this topic. Human studies have
shown that a reduction in pain threshold after long-term
psychoemotional stress probably occurs due to a reduction in
the activity of the brain’s opioid system (Ashkinazi and
Vershinina, 1999). Previous data from our group also suggest
involvement of the opioid system in the hyperalgesic response
induced by prolonged restraint stress (Torres et al., 2001b, 2003;
Dantas et al., 2005) Furthermore, activation of stress-related
circuitry in the hypothalamus activates pain-facilitating neurons
in the rostral ventromedial medulla to produce hyperalgesia (for
review, see Martenson et al., 2009), suggesting possible changes
in brain activity. Another possibility is increased expression of
pro-inflammatory cytokines, such as interleukin-1b and tumor
necrosis factor (TNFa), in brain tissue and blood due to stress
conditions. These cytokines are closely related to painful andinflammatory diseases, and their release is increased under
stressful conditions (for review, see Goshen and Yirmiya, 2009).
In view of the neuroplastic effects of chronic stress on pain-
related neural circuitry, deactivation of the stress-induced pain-
related neural changes would be best achieved with techniques
to induce neuroplasticity (Brunoni et al., 2011). One simple but
powerful technique is transcranial direct current stimulation
(tDCS). This technique produces modulation of neural activity
via small electrical currents that, when applied as a direct
current (DC) component, polarize neural tissue, inducing sig-
nificant changes in the restingmembrane threshold (Zaghi, 2010)
and subsequent changes in synaptic plasticity, as recently shown
in an elegant animal model in mice brain slices DC stimulation
(Fristch et al., 2010). In addition, it carries little risk and produces
little discomfort, and, with repeated sessions, may produce
enduring effects (Poreisz et al., 2007). Previous studies have
shown that excitability-enhancing anodal tDCS is effective in
reducing pain in patients with fibromyalgia (Fregni et al., 2006a)
and spinal cord injury (Fregni et al., 2006b). In addition, anodal
and cathodal tDCS of the primary motor cortex and dorsolateral
prefrontal cortex have been associated with significant changes
in experimental pain in healthy subjects (Reidler et al., 2012;
Grundman et al., 2011) Finally, the neuromodulatory effects of
tDCS have also been consistently demonstrated in animals, such
as in rat models of focal epilepsy (Liebetanz et al., 2006), memory
(Dockery et al., 2011), Parkinson’s disease (Li et al., 2011), and
acute stroke (Wachter et al., 2011)
Given the importance of chronic pain and the variability in its
pathophysiology, investigation of techniques that can modulate
neural mechanisms is relevant to the development of more
rational therapies. Non-invasive stimulation techniques, such as
tDCS, may be suitable for treatment of chronic pain. Thus, we
investigated whether tDCS reverses the hyperalgesia and allody-
nia induced by chronic restraint stress. We also measured its
effect on serum levels of corticosterone and interleukin-1b, as
well as TNFa levels in the hippocampus. The importance of this
study lies in the fact that it provides, for the first time, evidence
that tDCS can reverse the detrimental effects of a specific causal
factor of pain on the pain system. Because such a controlled
study (i.e. one including control of level of exposure, timing of
application of intervention in relation to exposure, and certain
measures in the hippocampus) would not be possible in humans
due to ethical issues, this study provides invaluable data for the
development of tDCS as a therapeutic tool in chronic pain.2. Results
2.1. Basal measure after chronic stress and effects of tDCS
on allodynia after the end of tDCS treatment as measured by
the von Frey test
When the stress group was divided into the stress, stressþ-
sham tDCS, and stressþactive tDCS groups, we again observed
Fig. 2 – Basal measure, immediately and 24 h after the end
of tDCS treatment on hyperalgesia induced by chronic rats
evaluated with the hot-plate test. Data presented as
mean7SEM of response latency (time to onset of paw-
licking or jumping) in seconds (s). Groups: C, control; S,
stress; SS, stressþsham; SN, stressþneuromodulation.
nSignificant difference versus control group (C) (one-way
ANOVA/Tukey, Po0.05, n¼9–13). #Significant difference ver-
sus the control (C) and stressþtDCS (SN) groups (one-way
ANOVA/Tukey, Po0.05, n¼9–13).
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control group and the other groups (C, 65.7173.39 g; S,
49.0772.63 g; SS, 45.3673.34 g; SN, 53.1072.23 g; one-way
ANOVA/Tukey’s test, F(P¼0.001, n¼9–12/group, Fig. 1). We
tested whether tDCS treatment was associated with a signifi-
cant change in allodynia as compared with the other no-tDCS
groups. We conducted an ANOVA testing group differences
immediately and 24 h after treatment adjusting for baseline
values (including pre-tDCS as the covariate in this ANOVA
model). We did not find a significant effect of time (F(1,44)¼
0.05, P¼0.82), neither in the interaction timengroup (F(3,44)¼
1.89, P¼0.14), suggesting that after treatment, there was no
differences in group behavior over time. But, we found a
significant effect of group (F(3,44)¼3.87, P¼0.015) considering
results after treatment. Post hoc analysis confirmed that SN
group showed significant differences as compared with SS
group (P¼0.028). Interestingly, the difference between SN and
C that we observed at baseline disappeared after tDCS treat-
ment, confirming that after tDCS, animals’ behavior were
similar to the non-stress control group. Although there was
also a difference between S and C (P¼0.012), there was no
difference between S and SN (P¼0.28), suggesting likely a lack
of power for this later analysis.2.2. Basal measure after chronic stress and effects of tDCS
on nociception immediately and 24 h after the end of tDCS as
measured by the hot plate test
We then performed similar analysis for the hot plate test. We
initially tested whether tDCS treatment was associated with a
significant change in hyperalgesia as compared with the
other no-tDCS groups (C, 5.75þ0.41 s; S, 2.7070.15 s; SS,
3.0870.90 s; SN, 3.6270.59 s; one-way ANOVA/Tukey’s test,
F(P¼0.000, n¼9–12/group, Fig. 2). Same ANOVA controlled for
baseline differences disclosed similar findings: no significant
effect of time (F(1,44¼3.90), P¼0.054) and no significant
interaction timengroup (F(3,44)¼0.31, P¼0.7320, suggesting
that after treatment, there was no differences in groupFig. 1 – Basal measure, immediately and 24 h after the end of
tDCS treatment on alodynia induced by chronic stress eval-
uated with the von Frey test. Data presented as mean7SEM of
withdrawal response in grams (g). Groups: C, control; S, stress;
SS, stressþsham; SN, stressþneuromodulation. Significant
difference versus control group (C) (one-way ANOVA/Tukey,
Po0.05, n¼9–13). #Significant difference versus the control (C)
and stressþtDCS (SN) groups (one-way ANOVA/Tukey, Po0.05,
n¼9–13).behavior over time. But, we found a significant effect of
group (F(9,42)¼7.08, P¼0.0000) considering results after treat-
ment. Here post hoc analysis confirmed that SN group
showed significant differences as compared with SS group
(P¼0.000) and S group (P¼0.002). Similarly the difference
between SN and C that we observed at baseline also
disappeared after tDCS treatment (P¼1.000), confirming
that after tDCS, animals behavior was similar to the non-
stress control group.
2.3. Effects of tDCS on serum corticosterone and
interleukin-1b levels after the end of tDCS treatment
No effect of stress or tDCS treatment was observed in serum
levels of corticosterone (C, 385.907171.54 nmol/L; S, 295.737
158.72 nmol/L; SS, 418.02 789.90 nmol/L; SN, 424.857102.17
nmol/L; one-way ANOVA/Tukey’s test, P40.05, n¼6–7, Fig. 3A)
or interleukin-1b (C, 46.7674.93 pg/L; S, 51.22711.85 pg/L; SS,
58.3877.45 pg/L; SN, 42.2173.90 pg/L; one-way ANOVA/Tukey’s
test, P40.05, n¼3–6, Fig. 3B).
2.4. Effects of tDCS on hippocampal TNFa levels after the
end of tDCS treatment
We observed a significant between-group difference in TNFa
levels in the hippocampus. The active tDCS group showed
decreased levels of TNFa in hippocampus in comparison to
the other groups (C, 128.76728.65 pg/L; S,126.77713.00 pg/L;
SS, 123.2675.22 pg/L; SN, 52.5072.00 pg/L one-way ANOVA/
Tukey’s test, Pr0.05, n¼3–4, Fig. 4).3. Discussion
In this study, we demonstrated that tDCS stimulation effec-
tively reversed the hyperalgesia and allodynia induced by the
Fig. 3 – Panel A: Evaluation of serum corticosterone levels of
chronic stressed rats 48 h after the end of tDCS treatment.
Data presented as mean7SEM of serum corticosterone level
in nmol/L. Groups: C, control; S, stress; SS, stressþsham; SN,
stressþneuromodulation. There were no significant between-
group differences (one-way ANOVA, P40.05, n¼3–4). Panel B:
Evaluation of serum interleukin-1b levels of chronic stressed
rats 48 h after the end of tDCS treatment. Data presented as
mean7SEM of serum interleukin-1b level in pg/mL. Groups: C,
control; S, stress; SS, stressþsham; SN, stressþneuromodula-
tion. There were no significant between-group differences
(one-way ANOVA, P40.05, n¼6–3).
Fig. 4 – Evaluation of hippocampal TNFa levels of chronic
stressed rats 48 h after the end of tDCS treatment. Data
presented as mean7SEM of hippocampal TNFa levels in pg/
mL. Groups: C, control; S, stress; SS, stressþsham; SN,
stressþneuromodulation. nSignificant difference in relation
to other groups (one-way ANOVA/Tukey, Po0.05, n¼3–4).
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least 24 h, which demonstrates the cumulative effects of
repetitive tDCS treatment, as, in the previous study, theantinociceptive effect of one session of transcranial eletros-
timulation in rats disappeared within 15 min after cessation
of electrical stimulation (Nekhendzy et al., 2004). The hyper-
algesic effect was assessed by two behavioral components on
hot plate (paw licking and jumping), both considered
supraspinally integrated responses. This constitutes, at least
in part, the rationale for testing of the antihyperalgesic effect
of tDCS. Given our electrode montage, it is conceivable that
most of the effects found in this study were due to cortical
modulation. In this scenario, it is likely that effects of
transcranial stimulation on pain relief depend on the projec-
tion of fibers from cortical structures to other neural areas
involved in pain processing, such as the thalamus and
brainstem nuclei, which could activate non-nociceptive neu-
rons (Drouot et al., 2002; Lefaucheur et al., 2006). Thus, we
can suggest that stimulation activates descending inhibitory
pathways, suppressing pain through a top–down modulation
mechanism (Lima and Fregni, 2008).
Although anodal tDCS has been shown to induce pain relief
in human studies (for a review, see Mylius et al., 2012), this
study fills a critical gap in the knowledge of the field, as we
show that consecutive sessions of tDCS can reverse chronic
stress-induced pain. In our study, we were able to control the
source of pain, thus providing a homogeneous sample in
terms of chronic pain mechanisms and demonstrating the
effects of tDCS in this condition. In this context, we will
briefly review the putative mechanisms involved in the
development of hyperalgesia after repeated restraint stress.
Previous studies have suggested that this phenomenon could
be related to changes in central or peripheral opioid activity
(Torres et al., 2001b, 2003; Dantas et al., 2005). The absence of
novelty-induced antinociception in these animals supports
this theory (Torres et al., 2001b). Exposure of rats to a novel
environment is known to be followed by mild, naloxone-
reversible antinociception (Siegfried et al., 1987). Opioid
receptors can be highly plastic, as reflected by their suscept-
ibility to modifications by various pharmacological and beha-
vioral manipulations (for a review, see Drolet et al., 2001).
Dantas et al. (2005) showed decrease in binding of opioid
receptors in the hippocampus and cerebral cortex. Addition-
ally, Torres et al. (2003) demonstrated that animals subjected
to chronic restraint stress for 6 weeks needed high doses of
morphine to exhibit an analgesic response, suggesting that
prolonged stress could lead to longer-lasting changes in the
neural systems involved in nociceptive modulation. On the
other hand, in acute stress, the opiate system seems to be
modulated in the opposite direction. In fact, the previous
study has demonstrated that animals subjected to acute
stress show an increase in the magnitude and duration of
the analgesic effect to some opiate agonists (Calcagnetti and
Holtzman, 1992).
Other important finding of this study was that corticoster-
one and interleukin-1b levels in serum did not present
statistically significant changes by the tDCS sessions and/or
chronic restraint stress. These results are consistent with the
literature, which has shown that chronic restraint stress
leads to disorganization and deregulation of HPA axis stress
responses (for a review, see Goshen and Yirmiya, 2009).
In addition, we showed that hippocampal TNFa levels were
not increased by chronic restraint stress, unlike the
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hippocampus after 40 days of variable stress (Tagliari et al.,
2011). This result was due to the long period of stress used in
this study—almost twice cited in the Tagliari paper. There-
fore, this reaction was probably reestablished by an adaptive
response. On the other hand, hippocampal TNFa levels were
significantly decreased in the group that received tDCS as
compared with other groups. As TNFa is a proinflammatory
cytokine, this could be related to the effects of tDCS on
reversal of maladaptative changes in the pain system
induced by chronic restraint stress. Hence, one possible mode
of action of anodal tDCS is by decreasing hippocampal TNFa
levels, causing an anti-inflammatory and anti-hyperalgesic
response, even considering normal baseline (pre-stimulation)
TNFa levels in the hippocampus.
Although the mechanisms underlying tDCS-mediated pain
regulation have yet to be elucidated, its mechanisms of action
involve changes in the neuronal electrical membrane potential
and modifications in the synaptic microenvironment. Changes
in synaptic strength are NMDA receptor-dependent or can alter
GABAergic activity (Liebetanz et al., 2002; Nitsche et al., 2003a;
Stagg et al., 2009). The tDCS also interferes with brain excit-
ability through modulation of intracortical and corticospinal
neurons (Nitsche et al., 2005; Ardolino et al., 2005). The effects
of tDCS might be similar to those observed in long-term
potentiation (LTP), as demonstrated in an animal study that
used anodal motor cortex stimulation (Fritsch et al., 2010).
Experiments with spinal cord stimulation have shown that
the effects of tDCS are also non-synaptic, possibly involving
transient changes in the density of protein channels located
below the stimulating electrode (Cogiamanian et al., 2008) or
due to glial changes (Radman et al., 2009). Given that a constant
electric field displaces all polar molecules and that most
neurotransmitters and receptors in the brain have electrical
properties, tDCS might also influence neuronal function by
inducing prolonged neurochemical changes (Stagg et al., 2009;
Cogiamanian et al., 2008).
In addition to neurochemical changes, it is known that
tDCS also has a significant effect on current blood flow. Some
experiments combining tDCS and transcranial laser Doppler
flowmetry (LDF) in a rat model demonstrated that tDCS
induces sustained changes on current blood flow. These
changes were polarity-specific; anodal tDCS leads to an
increase, whereas cathodal tDCS leads to a decrease in
current blood flow (Wachter et al., 2011). Whether increased
metabolic activity in the experimental model of chronic pain
is involved in the reversal of hyperalgesia has yet to be
determined.
According to Fertonani et al. (2010), the long-term effects of
tDCS also involve glutamatergic NMDA receptors, and synap-
tic plasticity is also dependent on NMDA receptors. D-cyclo-
serine, a partial NMDA agonist, has been shown to selectively
potentiate the duration of motor cortical excitability
enhancements induced by anodal tDCS, but not the decrease
in excitability induced by cathodal stimulation. A patient
with chronic pain was successfully treated with repeated
applications of tDCS over the motor cortex combined with D-
cycloserine and dextromethorphan administration to prevent
recurrence of pain (Antal and Paulus, 2011). The analgesic
effect of tDCS could be mediated by modulatory effects inpain sensation in several neurotransmitter systems, includ-
ing opioid, adrenergic, substance P, glutamate and neurokinin
receptors (Morgan et al., 1994; Wu et al., 2000). It leads to a
cascade of events resulting in the modulation of synaptic
neural chains that include several thalamic nuclei, the limbic
system, brainstem nuclei, and the spinal cord (Lima and
Fregni, 2008).
It has been demonstrated that pain relief induced by
invasive cortical stimulation is also mediated by activation
of the endogenous opioid system. In fact, motor cortex
stimulation produces activation of the cortical segment and
acts on intracortical interneurons. Stimulation of these fibers
spreads to different areas thalamic cortical projections,
cortical–cortical lateral projections and local cortical connec-
tions (Lima and Fregni, 2008). We can hypothesize that the
results obtained might depend on the aforementioned
mechanisms. However, we did not measure the duration of
the antihyperalgesic effect observed.
Viewed as a whole, our findings support the hypothesis of
an antihyperalgesic and antiallodynic effect of tDCS.
Although the mechanisms underlying this effect remain
unclear, the evidence suggests that they include non-
synaptic and synaptic mechanisms alike. The non-synaptic
mechanism would include changes which, apart from reflect-
ing local changes in ionic concentrations, could arise from
alterations in transmembrane proteins and from electrolysis-
related changes in H(þ), induced by exposure to a constant
electric field (Ardolino et al., 2005). The synaptic mechanisms
would involve neuroplastic alterations, such as changes in
the strength of connections, representational patterns, or
neuronal properties, either morphological or functional
(Antal et al., 2006). tDCS induces prolonged neuronal excit-
ability and activity changes in the human brain via altera-
tions in neuronal membrane potential, resulting in the
prolonged synaptic efficacy changes.
One important question that has yet to be fully elucidated
is optimal electrode placement for induction of analgesic
effects (Fregni, 2010). It is not clear whether the effects are
mainly due to anodal stimulation of frontal areas (including M1)
or associated with cathodal stimulation of the contralateral
area, although there is extensive evidence showing that
modulation of M1 is critically involved with pain modulation,
as shown by modeling studies (Mendonca et al., 2011; DaSilva
et al., 2012) and high-definition-tDCS(HD-tDCS) (Borckardt
et al., 2012). Finally, another important issue is the associa-
tion between electrode montage and shunting. Although our
montage may be associated with shunting, it has previously
proved effective, such as in the Takano et al. (2011) study.
These authors examined the effectiveness of tDCS using
functional magnetic resonance imaging (fMRI) and the signal
intensities of fMRI in the frontal cortex and nucleus accum-
bens, and found significant increases in activity after anodal
tDCS exposure in rats. In addition, in silicon finite element
model studies have shown that even with close electrodes,
such as those used in HD-tDCS, a significant amount of
current is injected and reaches cortical areas (Minhas, 2010;
Datta, 2009). On the basis of these considerations, we decided
to use a cephalic montage as this has been the most widely
used method in humans. In fact, a recent study in humans
showed that extra-cephalic montages were less effective to
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limitation, also discussed in a recent review, is extrapolation
of these results to humans (Volz et al., 2012). In this context,
this study, to the best of our knowledge, was the first to show
that tDCS can reverse the effects of maladaptive plasticity as
expressed by behavioral changes and measured by TNFa
levels. On the other hand, one limitation of the study was
the lack of difference between one of the analysis for von
Frey test – S vs. SN – probably because of less sensitivity of
this measurement as compared to hot plate test and also
because of differences what these measurements index such
as hot plate related to hyperalgesia and von Frey related to
allodynia.
In summary, we showed that tDCS was able to reverse
completely the detrimental effects of chronic stress on the
pain system, as expressed by hyperalgesia and allodynia, and
that this effect continued for 24 h. Serum levels of corticos-
terone and interleukin-1b were not changed by tDCS sessions
or chronic restraint stress, but hippocampal TNFa levels
decreased. Given that, in this study, animals were exposed
to the same level of stress under the same conditions, our
findings support further exploration of tDCS as a therapeutic
tool early in the exposure to stressful situations that may
lead to chronic pain, such as post-traumatic stress disorder,
and demonstrate one possible pathway of anodal tDCS
treatment. Future studies should also consider assessing
other outcomes of stress response, including other behavioral
outcomes, as well as measurement of other biochemical
variables, such as PCPA (inhibitor of serotonin synthesis),
AMPT (inhibitor of tyrosine hydroxylase) and naloxone, to
provide a better understanding of the effects of chronic
restraint stress on mood and anxiety and further elucidate
and optimize this intervention into a potential clinical tool
for stress-related conditions.4. Experimental procedures
4.1. Animals
Sixty-day-old male Wistar rats weighing 180–230 g were used.
Experimentally naive animals were housed in groups of five
in 493416 cm polypropylene home cages. All animals
were kept on a standard 12-hour light/dark cycle (lights on
at 07:00 a.m. and lights off at 07:00 p.m.) in a temperature-
controlled environment (2272 1C). Animals had access to
water and chow ad libitum. All experiments and procedures
were approved by the Institutional Committee for Animal
Care and Use (GPPG-HCPA protocol No. 100.381) and per-
formed in accordance with the Guide for the Care and Use of
Laboratory Animals 8th edition (2011). Animal handling and
all experiments were performed in accordance with Interna-
tional Guidelines for Animal Welfare and Measures were
taken to minimize animal pain and discomfort. The experi-
ment used the minimum number of animals required to
produce reliable scientific data.
To control the possible effect of outliers, we excluded rats
which did not present any response on behavioral testing. All
the experimenters were blinded to condition (active or sham
tDCS) during post-treatment behavioral testing.4.2. Chronic restraint stress
The animals were subjected to 1 h of restraint daily, 5 days a
week for 11 weeks. Restraint was applied by placing the
animal in 25 7 cm plastic bottle with a 1-cm hole at the far
end for breathing (Ely et al., 1997 with modifications). The
animal was unable to move. The control group was not
subjected to restraint. These procedures were always per-
formed between 08:00 h and 09:00 h. Restraint sessions con-
tinued during the behavioral test period and during tDCS
sessions, which were carried out in the afternoon. The
animals were divided into four groups (n¼12–13): control
(C), stress (S), stressþsham tDCS (SS) and stressþtDCS (SN).
After 11 weeks of chronic stress exposure, behavioral tests
were performed in the afternoon.4.3. Pain outcome I: von Frey test
Mechanical allodynia was assessed before, immediately and
24 h after the end of tDCS treatment using an automatic von
Frey esthesiometer (Insight, S ~ao Paulo, Brazil). This is an
adaptation of the classical von Frey filaments test in which
pressure intensity is recorded automatically after paw
removal (Vivancos et al., 2004). It has been proposed that
tactile hypersensitivity is likely to be the consequence of a
change in function and a phenotypic switch in primary
afferent neurons innervating the inflamed tissue and the
pattern of excitation they produce in spinal neurons. This
assumption was partially confirmed by the finding that a
subpopulation of A beta primary afferent neurons came to
express substance P after conditioning inflammation, thereby
enhancing synaptic transmission in the spinal cord and
exaggerating the central response to innocuous stimuli (Ma
and Woolf, 1996; Neumann et al., 1996).
Rats were placed in 122017 cm polypropylene cages
with wire grid floors and acclimatized for 15 min, 24 h prior to
the test, as the novelty of the apparatus itself can induce
antinociception (Netto et al., 2004). For testing, a polypropy-
lene tip was placed perpendicularly underneath the mesh
floor and applied to one of the five distal footpads with a
gradual increase in pressure. A tilted mirror below the grid
provided a clear view of the animal’s hind paw. The test
consisted of poking the hind paw to provoke a flexion reflex
followed by a clear flinch response after paw withdrawal. The
intensity of the stimulus was automatically recorded when
the paw was withdrawn. Three successive von Frey readings
were averaged, and these averages were used as the final
measurements. The paw withdrawal threshold was
expressed in grams (g) (Vivancos et al., 2004).4.4. Pain outcome II: hot plate
The hot plate test was carried out to assess the effects of
tDCS on the thermal nociceptive threshold (Woolfe and
Macdonald, 1944). This test was assessed before, immediately
and 24 h after the end of tDCS treatment. We used the hot-
plate test to determine changes in latency as an indicator of
modifications of the supraspinal pain process (Ossipov et al.,
1995), as licking or jumping responses during this test are
b r a i n r e s e a r c h 1 4 8 9 ( 2 0 1 2 ) 1 7 – 2 6 23considered to be the result of supraspinal sensory integration
(Caggiula et al., 1995; Rubinstein et al., 1996).
The hot plate was pre-heated and kept at a temperature of
5570.5 1C. All rats were acclimated to the hot plate for 5 min,
24 h prior to testing, as, again, the novelty of the apparatus
itself can induce antinociception (Netto et al., 2004). Rats were
placed in glass funnels on the heated surface and the nocicep-
tive threshold was assessed recording to the time taken to first
response (foot licking, jumping, or rapidly removing paws), as
described by Minami et al. (1994). Response was recorded in
seconds (s) and a cutoff time of 20 s was used.Fig. 5 – Panel A: tDCS electrode placement. The cathodal
stimulus electrode was positioned at the midpoint of the lateral
angle of the eyes, and the anodal electrode is positioned over
the neck and shoulder areas. Panel B: tDCS stimulation
procedure. The stimulator was placed onto the thorax with a
corset and the electrodes were fixed onto the rat’s head.4.5. Transcranial direct current stimulation (tDCS)
After 11 weeks of chronic stress exposure, the rats of SN were
subjected to a 20-min session of anodal tDCS every afternoon
for 8 days. This period was established because tDCS has been
shown to modify cortical excitability for up to 1 h after one
session of stimulation (Nitsche and Paulus, 2000; Nitsche et al.,
2003b). However, repetitive tDCS application has demonstrated
better and longer-lasting effects on pain relief, and in recent
study our group showed antihyperalgesic response in paw
inflamed rats with this treatment period (Laste et al., 2012).
The direct current was delivered from a battery-driven, con-
stant current stimulator using ECG electrodes with conductive
adhesive hydrogel. Rats’ heads were shaved for better adher-
ence and the electrodes were trimmed to 1.5 cm2 for better fit.
After placement, electrodes were fixed onto the head with
adhesive tape (MicroporeTM) and covered with a protective
mesh to prevent removal (Fig. 5A).
The anodal electrode was positioned between the ears,
from the neck of the rat (parietal cortex) (Fig. 5B) (Takano
et al., 2011 with modifications), so as to mimic anodal
placement in human pain studies (Mendonca et al., 2011;
Dasilva et al., 2012). The cathodal electrode was positioned at
the midpoint of the lateral angle of the eyes (supraorbital
area). The electrodes were placed on the skin in a similar
manner to that used in human studies of tDCS for pain
(Nitsche et al., 2008; Antal and Paulus, 2011; Rosen et al., 2009;
Fregni et al., 2006c).
A constant current of 0.5 mA intensity was applied for 20 min
(Fregni et al., 2006b; Dockery et al., 2011; Wachter et al., 2011;
Liebetanz et al., 2006). According to an earlier study (Liebetanz
et al., 2009), a constant current of 1mA intensity causes skin
lesions, as current density is comparatively much higher than
the traditional 1 mA tDCS using large pads in humans. We
therefore chose to use 0.5 mA, an intensity that has also been
used in other animal studies. In addition, in our study, electro-
des were fixed onto the skin. We did not observe any lesions
with montage and current intensity.
An important point to consider was that this model required
neither anesthesia nor surgery, unlike models used in the
previous tDCS studies in rats (Dockery et al., 2011; Wachter
et al., 2011; Liebetanz et al., 2006). In fact, this represents a
strength in this study, as volatile anesthesia (such as isoflurane)
has been shown to decrease excitatory and increase inhibitory
transmission (Gomez and Guatimosim, 2003; Ouyang and
Hemmings, 2005), altering BDNF expression and thus neuro-
plasticity (Lu et al., 2006; Head et al., 2009). Wewere thus able toremove this confounding factor in our study by adapting a
human model using ECG electrodes (Fregni et al., 2006c).
For sham stimulation, the electrodes were placed in the
same positions as for real stimulation; however, the stimu-
lator was turned off after 30 s of stimulation so the animals
could maintain continuity of the physical sensation of real
tDCS conditions (Gandiga et al., 2006).
4.6. Blood sampling and tissue collection
Forty-eight hours after tDCS treatment, the animals were
killed by decapitation. Trunk blood was collected and cen-
trifuged at 5000 g for 5 min at room temperature. Animals
were killed by an experienced investigator. Serum and hip-
pocampus were frozen at 70 1C for subsequent analysis.
4.7. Analyses of corticosterone and interleukin-1b serum
levels
Serum interleukin-1 and corticosterone levels were determined
using commercially available enzyme-linked immunosorbent
b r a i n r e s e a r c h 1 4 8 9 ( 2 0 1 2 ) 1 7 – 2 624assay (ELISA) kits for rat interleukin-1 (Uscn Life Science Inc.) or
corticosterone (IBL Corticosterone Kit), according to manufac-
turer instructions. The results are expressed in pg/mL and
nmol/L, respectively.
4.8. Analysis of TNFa immunocontent
TNF analysis was performed on hippocampus homogenates.
TNF levels were measured by a commercially available
enzyme-linked immunosorbent assay (ELISA) kit for rat
tumor necrosis factor-alpha (Uscn Life Science Inc.), accord-
ing to manufacturer protocols. The results are expressed
in pg/mL.
4.9. Statistical analysis
The results are presented as the mean7standard error of the
mean (SEM). As data were normally distributed, we assessed
the difference between groups using one-way ANOVA with
Tukey’s test when necessary. P-values less than 0.05 were
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